Interview with CEO Göran Forsberg regarding the significance of Avalo's financing and development of IL-1beta antibody
Watch the interview in Swedish hereCEO Göran Forsberg interviewed on new results with CAN10 and external validation of IL-1 blockade during inflammatory disease
Watch the interview in Swedish hereRedeye interviews CEO Göran Forsberg about new results on nadunolimab and alleviation of neuropathy during chemotherapy
Watch the interview in Swedish here(R) = Regulatory press releases